freeline.lifeHealthcareFounded: 2015Funding to Date: $205.53MM
Freeline is a clinical-stage, fully integrated, next generation, systemic AAV-based gene therapy company with the ambition of transforming the lives of patients suffering from inherited systemic debilitating diseases.
View Enterprise Value for Freeline Therapeutics.